Detalhe da pesquisa
1.
An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma.
Blood;
131(7): 746-758, 2018 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29284597
2.
Genetic variants in BRIP1 (BACH1) contribute to risk of nonsyndromic cleft lip with or without cleft palate.
Birth Defects Res A Clin Mol Teratol;
100(9): 670-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25045080
3.
Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity.
Front Oncol;
14: 1394393, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38651147
4.
Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real-world practice.
Cytometry B Clin Cytom;
104(4): 304-310, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36370149
5.
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy.
J Immunother Cancer;
11(6)2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37399355
6.
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease.
Nat Commun;
13(1): 7868, 2022 12 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36550101
7.
Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.
Front Immunol;
12: 618610, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33717112
8.
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma.
Clin Cancer Res;
26(13): 3443-3454, 2020 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32220887